140 related articles for article (PubMed ID: 32194908)
1. SET7 interacts with HDAC6 and suppresses the development of colon cancer through inactivation of HDAC6.
Zhang SL; Du X; Tan LN; Deng FH; Zhou BY; Zhou HJ; Zhu HY; Chu Y; Liu DL; Tan YY
Am J Transl Res; 2020; 12(2):602-611. PubMed ID: 32194908
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK/ERK signal pathway.
Zhang SL; Zhu HY; Zhou BY; Chu Y; Huo JR; Tan YY; Liu DL
Onco Targets Ther; 2019; 12():2409-2419. PubMed ID: 31118659
[No Abstract] [Full Text] [Related]
3. RASSF1A Suppresses Cell Migration through Inactivation of HDAC6 and Increase of Acetylated α-Tubulin.
Jung HY; Jung JS; Whang YM; Kim YH
Cancer Res Treat; 2013 Jun; 45(2):134-44. PubMed ID: 23864847
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
Vanaja GR; Ramulu HG; Kalle AM
Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin.
Zhao Z; Xu H; Gong W
Protein Pept Lett; 2010 May; 17(5):555-8. PubMed ID: 19961433
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic factors MeCP2 and HDAC6 control α-tubulin acetylation in cardiac fibroblast proliferation and fibrosis.
Tao H; Yang JJ; Shi KH; Li J
Inflamm Res; 2016 May; 65(5):415-26. PubMed ID: 26975406
[TBL] [Abstract][Full Text] [Related]
7. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
8. Isoproterenol increases histone deacetylase 6 expression and cell migration by inhibiting ERK signaling via PKA and Epac pathways in human lung cancer cells.
Lim JA; Juhnn YS
Exp Mol Med; 2016 Jan; 48(1):e204. PubMed ID: 27534532
[TBL] [Abstract][Full Text] [Related]
9. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
10. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.
Zhang Y; Kwon S; Yamaguchi T; Cubizolles F; Rousseaux S; Kneissel M; Cao C; Li N; Cheng HL; Chua K; Lombard D; Mizeracki A; Matthias G; Alt FW; Khochbin S; Matthias P
Mol Cell Biol; 2008 Mar; 28(5):1688-701. PubMed ID: 18180281
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
[TBL] [Abstract][Full Text] [Related]
13. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
14. Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly.
Ran J; Yang Y; Li D; Liu M; Zhou J
Sci Rep; 2015 Aug; 5():12917. PubMed ID: 26246421
[TBL] [Abstract][Full Text] [Related]
15. New HDAC6-mediated deacetylation sites of tubulin in the mouse brain identified by quantitative mass spectrometry.
Liu N; Xiong Y; Li S; Ren Y; He Q; Gao S; Zhou J; Shui W
Sci Rep; 2015 Nov; 5():16869. PubMed ID: 26581825
[TBL] [Abstract][Full Text] [Related]
16. HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia.
Xiang W; Guo F; Cheng W; Zhang J; Huang J; Wang R; Ma Z; Xu K
Oncol Rep; 2017 Jul; 38(1):229-236. PubMed ID: 28586053
[TBL] [Abstract][Full Text] [Related]
17. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
Skoge RH; Ziegler M
J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
[TBL] [Abstract][Full Text] [Related]
18. SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer.
Song Y; Zhang J; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Tumour Biol; 2016 Jul; 37(7):9311-22. PubMed ID: 26779630
[TBL] [Abstract][Full Text] [Related]
19. Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer.
Vuletić A; Mirjačić Martinović K; Spasić J
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258065
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression.
Akiyama Y; Koda Y; Byeon SJ; Shimada S; Nishikawaji T; Sakamoto A; Chen Y; Kojima K; Kawano T; Eishi Y; Deng D; Kim WH; Zhu WG; Yuasa Y; Tanaka S
Oncotarget; 2016 Jan; 7(4):3966-83. PubMed ID: 26701885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]